Published: October 25, 2025
0
0
0
Clinical Pearls – Acute Upper Gastrointestinal Bleeding (AUGIB): 2025 Update @drkeithsiau 🔍 1. Overview AUGIB remains a medical emergency with ~9% mortality despite progress. Latest evidence (2020–2025) emphasizes early risk stratification, optimized resuscitation, precision
“SGLT2 inhibitor + GLP-1 RA—an emerging powerhouse pairing that unites vascular, cardiac, and renal protection to halve mortality in type 2 diabetes.” Both SGLT2 inhibitors and GLP-1 receptor agonists individually lower cardiovascular and renal risk in T2DM. Their actions
